Shabnam Kazmi

Shabnam Kazmi is an experienced commercial leader in the oncology pharmaceutical and biotech industry with a track record of bringing innovative oncology products to patients and building asset value by successfully managing bench-to-bedside drug development and commercialization. She has held executive roles at Bristol-Myers Squibb, Sanofi and Otsuka, managing global businesses and joint ventures. Shabnam has played key roles in the launch of three top oncology brands across solid tumors and hematology, and an $860M acquisition, fundraising and an IPO.